- Documento1422273_81098048EN_Leaflet_Karl-Fischer-Elektroden.pdfcaricato da
jhuampe
- DocumentoTasks of the Product Team on the Handling of the Initial Marketing Authorisation Applicationcaricato da
jhuampe
- DocumentoDraft Guideline on the Acceptability of Names for Human Productscaricato da
jhuampe
- DocumentoGuideline on the Acceptability of Names for Human Medicinal Products Processed Through the Centralised Procedurecaricato da
jhuampe
- DocumentoNRG Position Paper Re-use of Invented Names of Medicinalcaricato da
jhuampe
- DocumentoNRG Position Paper Re-use of Invented Names of Medicinal Productscaricato da
jhuampe
- DocumentoScientific Aspects and Working Definitions Forcaricato da
jhuampe
- DocumentoCompassionate Use for Centralised Medicinal Productscaricato da
jhuampe
- DocumentoOverview of Comments Received Oncaricato da
jhuampe
- DocumentoCommittee for Medicinal Products for Human Usecaricato da
jhuampe
- DocumentoProcedural Advice on CHMP_CAT Rapporteur_co-rapporteurcaricato da
jhuampe
- Documento28_anexo-15caricato da
jhuampe
- Documento24_anexo-11bcaricato da
jhuampe
- Documento01_prologocaricato da
jhuampe
- Documento06_capitulo-3caricato da
jhuampe
- DocumentoDirectiva 2001_83_CE 06 Noviembrecaricato da
jhuampe
- DocumentoTLS2200_UG_v4.04_ES[1]caricato da
jhuampe
- DocumentoElectrodes_for_Titration.pdfcaricato da
jhuampe
- DocumentoInstrumentcaricato da
jhuampe
- DocumentoWorking Procedures of the Pharmacopeial Discussion Group (PDG)caricato da
jhuampe